Dawn Schottlandt joined Chiasma in November 2019 as Vice President of Investor Relations and Corporate Communications. Prior to joining Chiasma, Dawn was the Vice President of Investor Relations and Corporate Communications at ArQule, a public biopharmaceutical company focused on oncology and rare diseases. She was previously the Director of Investor Relations at Thermo Fisher Scientific (NYSE: TMO), a leading life science tools company. She also worked at Elan Corporation as part of the Investor Relations team during the Tysabri launch. Dawn began her career on Wall Street as a buy side and sell side equity research analyst. Dawn holds a B.S. in Finance from Boston College and is a Chartered Financial Analyst (CFA).
VP Investor Relations & Corporate Communications